Tuberculosis--impact of the HIV epidemic

Comment

R Barker et al. S Afr Med J. 1997 Oct.

. 1997 Oct;87(10):1384.

No abstract available

Comment on

The increasing burden of tuberculosis in rural South Africa--impact of the HIV epidemic.
Wilkinson D, Davies GR. Wilkinson D, et al. S Afr Med J. 1997 Apr;87(4):447-50. S Afr Med J. 1997. PMID: 9254788

The increasing burden of tuberculosis in rural South Africa--impact of the HIV epidemic.
Wilkinson D, Davies GR. Wilkinson D, et al. S Afr Med J. 1997 Apr;87(4):447-50. S Afr Med J. 1997. PMID: 9254788
Managing tuberculosis case-loads in African countries.
Wilkinson D. Wilkinson D. Lancet. 1997 Mar 22;349(9055):882. doi: 10.1016/S0140-6736(05)61791-6. Lancet. 1997. PMID: 9121288 No abstract available.
The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity.
Bekker LG, Wood R. Bekker LG, et al. Clin Infect Dis. 2010 May 15;50 Suppl 3:S208-14. doi: 10.1086/651493. Clin Infect Dis. 2010. PMID: 20397950 Review.
HIV infection among patients with tuberculosis in KwaZulu/Natal, South Africa.
Colvin M, Karim Abdool SS. Colvin M, et al. Int J Tuberc Lung Dis. 1998 Feb;2(2):172. Int J Tuberc Lung Dis. 1998. PMID: 9562130 No abstract available.
Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G; Tugela Ferry Care and Research (TF CARES) Collaboration. Andrews JR, et al. J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121. J Infect Dis. 2007. PMID: 18181698 Review.

An immunoregulator nanomedicine approach for the treatment of tuberculosis.
Yang L, Chaves L, Kutscher HL, Karki S, Tamblin M, Kenney P, Reynolds JL. Yang L, et al. Front Bioeng Biotechnol. 2023 May 25;11:1095926. doi: 10.3389/fbioe.2023.1095926. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37304141 Free PMC article.